The increasing demand for ketamine, often for psychiatric ailments, presents significant challenges regarding its provision and secure shipping within the United States. Specific national laws govern such practice, necessitating compliance from suppliers. Moreover, preserving patient anonymity through meticulous packaging and legal transport chains